Sponsored Content | Whitepapers | Mammography | February 28, 2023
Fujifilm’s third generation digital mammography system, ASPIRE Cristalle (known as AMULET Innovality outside the United States), combines state-of-the-art imaging capabilities, a unique hexagonal close pattern detector design, and advanced image processing to maximize image quality and diagnostic accuracy for early detection of breast cancer

Fujifilm’s third generation digital mammography system, ASPIRE Cristalle (known as AMULET Innovality outside the United States), combines state-of-the-art imaging capabilities, a unique hexagonal close pattern detector design, and advanced image processing to maximize image quality and diagnostic accuracy for early detection of breast cancer. This paper describes the advantages of Comfort Comp, a feature designed to augment patient comfort through decreased compression without compromising image quality or workflow.

Although overall mortality rates for breast cancer have decreased in recent years, it remains the most common and the second deadliest cancer among women worldwide. In the US alone, an estimated 284,000 new breast cancer cases and over 44,000 related deaths occurred in 2021, highlighting the urgency of effective preventive strategies.

Early detection can save lives: the 5-year survival rate for breast cancer patients who are diagnosed in the early, localized stage is 99% compared to 26% if diagnosis occurs after spread to the lymph nodes. Regular screening via routine mammograms is our first line of defense and most powerful tool in the fight against breast cancer. However, despite being relatively inexpensive and widely available, approximately 35% of women over age 40 haven’t had a mammogram in more than two years in the US. Screening rates vary greatly around the world, but the fact remains–compliance with periodic screenings continues to be a major challenge to a potentially life-saving strategy.

Inadequate patient education about the importance of early detection and fear of receiving a cancer diagnosis are two of the major factors affecting screening compliance. Pain also ranks high on this list – breast compression during mammography is associated with discomfort and pain, and many patients are reluctant to undergo screening due to the expectation that it will hurt. Improving the patient experience therefore represents our best opportunity to encourage participation in routine screening.

Download the white paper.


Related Content

News | Breast Imaging

October 2, 2023 — Digital radiography company Swissray has announced a strategic partnership with Koning Corporation ...

Time October 02, 2023
arrow
News | Radiation Oncology

October 2, 2023 — Two liquid biopsy tests that look for the presence of human papillomavirus (HPV) in the blood ...

Time October 02, 2023
arrow
News | Women's Health

October 1, 2023 — In a first-of-its-kind study, people with breast cancer who underwent implant-based breast ...

Time October 01, 2023
arrow
News | Women's Health

October 1, 2023 — People who engage in sexual activity or vaginal dilation after chemoradiation treatment for cervical ...

Time October 01, 2023
arrow
News | Women's Health

September 29, 2023 — Hologic, Inc., a global leader in women’s health, announced a series of activities promoting the ...

Time September 29, 2023
arrow
News | Breast Imaging

September 27, 2023 — Researchers at Weill Cornell Medicine have discovered that radiation therapy combined with two ...

Time September 27, 2023
arrow
News | Mammography

September 26, 2023 — Artificial intelligence(AI) and machine learning tools have received a lot of attention recently ...

Time September 26, 2023
arrow
News | Mammography

September 22, 2023 — Hologic Inc. and Bayer announced an international partnership to deliver contrast-enhanced ...

Time September 22, 2023
arrow
News | Digital Pathology

September 22, 2023 — Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today ...

Time September 22, 2023
arrow
Feature | Breast Imaging | By Susan Harvey, MD, FSBI

In countries with organized screening programs, regular breast cancer screening has been a crucial tool in the clinician ...

Time September 22, 2023
arrow
Subscribe Now